Metataxonomic and Immunological Analysis of Feces from Children with or without Phelan-McDermid Syndrome

Claudio Alba1,2, Carmen Herranz1,2, Miguel A Monroy3

  • 1Department Nutrition and Food Science, Complutense University of Madrid, 28040 Madrid, Spain.

Microorganisms
|October 26, 2024
PubMed

Insights

Children with Phelan-McDermid syndrome (PMS) show altered gut bacteria and reduced short-chain fatty acids (SCFAs). These gut microbiome changes may influence neurodevelopmental and gastrointestinal symptoms in PMS.

Area of Science:

  • Neuroscience
  • Microbiology
  • Genetics

Background:

  • Phelan-McDermid syndrome (PMS) is a neurodevelopmental disorder.
  • Gut microbiota alterations are increasingly linked to neuropsychiatric conditions.

Purpose of the Study:

  • To investigate gut microbiota and immune profiles in children with PMS.
  • To compare these profiles against healthy controls.

Main Methods:

  • 16S rRNA gene sequencing for bacterial composition analysis.
  • Gas chromatography for short-chain fatty acid (SCFA) quantification.
  • Multiplex cytokine assay for immunological profiling.

Main Results:

  • Distinct gut microbiota composition in PMS patients, with lower abundance of *Faecalibacterium* and *Agathobacter*.
  • Reduced SCFA levels observed in children with PMS.
  • Tendency towards higher pro-inflammatory cytokines in PMS group, though not statistically significant.

Conclusions:

  • Children with PMS exhibit unique gut microbiota and SCFA profiles.
  • These gut alterations may contribute to PMS symptoms.
  • Potential for microbiota-targeted therapies in Phelan-McDermid syndrome.